Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma

Two CT features were developed to quantitatively describe lung adenocarcinomas by scoring tumor shape complexity (feature 1: convexity) and intratumor density variation (feature 2: entropy ratio) in routinely obtained diagnostic CT scans. The developed quantitative features were analyzed in two independent cohorts (cohort 1: n = 61; cohort 2: n = 47) of patients diagnosed with primary lung adenocarcinoma, retrospectively curated to include imaging and clinical data. Preoperative chest CTs were segmented semi-automatically. Segmented tumor regions were further subdivided into core and boundary sub-regions, to quantify intensity variations across the tumor. Reproducibility of the features was evaluated in an independent test-retest dataset of 32 patients. The proposed metrics showed high degree of reproducibility in a repeated experiment (concordance, CCC≥0.897; dynamic range, DR≥0.92). Association with overall survival was evaluated by Cox proportional hazard regression, Kaplan-Meier survival curves, and the log-rank test. Both features were associated with overall survival (convexity: p = 0.008; entropy ratio: p = 0.04) in Cohort 1 but not in Cohort 2 (convexity: p = 0.7; entropy ratio: p = 0.8). In both cohorts, these features were found to be descriptive and demonstrated the link between imaging characteristics and patient survival in lung adenocarcinoma.

[1]  M. Tsuboi,et al.  Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification. , 2013, Clinical radiology.

[2]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[3]  M. Prokop,et al.  Spiral and multislice computed tomography of the body , 2003 .

[4]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[5]  Jie Tian,et al.  Automated delineation of lung tumors from CT images using a single click ensemble segmentation approach , 2013, Pattern Recognit..

[6]  Xiangyu Yang,et al.  Quantifying Tumor Vascular Heterogeneity with Dynamic Contrast-Enhanced Magnetic Resonance Imaging: A Review , 2011, Journal of biomedicine & biotechnology.

[7]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[8]  Binsheng Zhao,et al.  Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. , 2009, Radiology.

[9]  R. Gillies,et al.  Quantitative imaging in cancer evolution and ecology. , 2013, Radiology.

[10]  Biao He,et al.  A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies , 2012, The Lancet.

[11]  M. Kuo,et al.  Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations. , 2014, Radiology.

[12]  David P. Dobkin,et al.  The quickhull algorithm for convex hulls , 1996, TOMS.

[13]  Howard Y. Chang,et al.  Decoding global gene expression programs in liver cancer by noninvasive imaging , 2007, Nature Biotechnology.

[14]  T. Stephenson.  Image analysis , 1992, Nature.

[15]  Brandon Whitcher,et al.  Quantifying spatial heterogeneity in dynamic contrast‐enhanced MRI parameter maps , 2009, Magnetic resonance in medicine.

[16]  K. Cibulskis,et al.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer , 2012, Nature Genetics.

[17]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.

[18]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[19]  K. Aldape,et al.  Identification of noninvasive imaging surrogates for brain tumor gene-expression modules , 2008, Proceedings of the National Academy of Sciences.

[20]  A. Rutman,et al.  Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. , 2009, European journal of radiology.

[21]  Michael K Gould,et al.  PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. , 2010, Chest.

[22]  Roberto Maroldi,et al.  Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy , 2013, European Radiology.

[23]  C. Jaffe.  Imaging and genomics: is there a synergy? , 2012, Radiology.

[24]  Samuel H. Hawkins,et al.  Reproducibility and Prognosis of Quantitative Features Extracted from CT Images. , 2014, Translational oncology.

[25]  Balaji Ganeshan,et al.  Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. , 2009, Radiology.

[26]  J. Smirniotopoulos,et al.  Glioblastoma multiforme: radiologic-pathologic correlation. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  M. O'Boyle.  Spiral and Multislice Computed Tomography of the Body , 2003 .

[28]  Quynh-Thu Le,et al.  Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. , 2014, Clinical lung cancer.

[29]  L. Marks,et al.  Local recurrence after surgery for early stage lung cancer , 2009, Cancer.

[30]  Leszek Wojnar,et al.  Image Analysis , 1998 .

[31]  Olivier Gevaert,et al.  Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. , 2012, Radiology.

[32]  K. Miles,et al.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.